Judge Henry L. Adams granted the motion of Novartis Pharmaceuticals Corporation (“NPC”) to apply New Jersey punitive damages law in a pharmaceutical products liability lawsuit filed in the Middle District of Florida by a Florida resident…
Novartis Pharmaceuticals secured dismissal of punitive damages demands in the Middle District of Florida, joining the vast majority of other courts in the Aredia/Zometa litigation in holding that New Jersey law governs the question of punitive…
After deliberating for fewer than forty-five minutes, a federal jury in Tampa, Florida returned a unanimous verdict in favor of Novartis Pharmaceuticals Corporation in a 3-week trial involving Aredia and Zometa, bisphosphonate medicines used to treat…
In 2006, plaintiffs in southern Florida filed a “pure bill of discovery” against Firm client Novartis Pharmaceuticals Corporation. A pure bill of discovery is a little-used Florida procedure, with parallels in a handful of other states,…